235 related articles for article (PubMed ID: 33320347)
1. Psychosocial outcomes following germline multigene panel testing in an ethnically and economically diverse cohort of patients.
Culver JO; Ricker CN; Bonner J; Kidd J; Sturgeon D; Hodan R; Kingham K; Lowstuter K; Chun NM; Lebensohn AP; Rowe-Teeter C; Levonian P; Partynski K; Lara-Otero K; Hong C; Morales Pichardo J; Mills MA; Brown K; Lerman C; Ladabaum U; McDonnell KJ; Ford JM; Gruber SB; Kurian AW; Idos GE
Cancer; 2021 Apr; 127(8):1275-1285. PubMed ID: 33320347
[TBL] [Abstract][Full Text] [Related]
2. Psychological impact of multigene cancer panel testing in patients with a clinical suspicion of hereditary cancer across Spain.
Esteban I; Vilaró M; Adrover E; Angulo A; Carrasco E; Gadea N; Sánchez A; Ocaña T; Llort G; Jover R; Cubiella J; Servitja S; Herráiz M; Cid L; Martínez S; Oruezábal-Moreno MJ; Garau I; Khorrami S; Herreros-de-Tejada A; Morales R; Cano JM; Serrano R; López-Ceballos MH; González-Santiago S; Juan-Fita MJ; Alonso-Cerezo C; Casas A; Graña B; Teulé A; Alba E; Antón A; Guillén-Ponce C; Sánchez-Heras AB; Alés-Martínez JE; Brunet J; Balaguer F; Balmaña J
Psychooncology; 2018 Jun; 27(6):1530-1537. PubMed ID: 29498768
[TBL] [Abstract][Full Text] [Related]
3. Impact of Panel Gene Testing for Hereditary Breast and Ovarian Cancer on Patients.
Lumish HS; Steinfeld H; Koval C; Russo D; Levinson E; Wynn J; Duong J; Chung WK
J Genet Couns; 2017 Oct; 26(5):1116-1129. PubMed ID: 28357778
[TBL] [Abstract][Full Text] [Related]
4. Disparities in cancer genetics care by race/ethnicity among pan-cancer patients with pathogenic germline variants.
Liu YL; Maio A; Kemel Y; Salo-Mullen EE; Sheehan M; Tejada PR; Trottier M; Arnold AG; Fleischut MH; Latham A; Carlo MI; Murciano-Goroff YR; Walsh MF; Mandelker D; Mehta N; Bandlamudi C; Arora K; Zehir A; Berger MF; Solit DB; Aghajanian C; Diaz LA; Robson ME; Brown CL; Offit K; Hamilton JG; Stadler ZK
Cancer; 2022 Nov; 128(21):3870-3879. PubMed ID: 36041233
[TBL] [Abstract][Full Text] [Related]
5. Patient-reported outcomes associated with reflex BRCA1/2 tumor and subsequent germline panel genetic testing for high-grade serous ovarian cancer.
McCuaig JM; Stockley TL; Ferguson SE; Vicus D; Brennenstuhl S; Ott K; Kim RH; Metcalfe KA
J Genet Couns; 2023 Apr; 32(2):503-513. PubMed ID: 36478486
[TBL] [Abstract][Full Text] [Related]
6. Informing models of cancer genetics care in the era of multigene panel testing with patient-led recommendations.
Underhill-Blazey M; Blonquist T; Chittenden A; Pozzar R; Nayak M; Lansang K; Hong F; Garber J; Stopfer JE
J Genet Couns; 2021 Feb; 30(1):268-282. PubMed ID: 32851753
[TBL] [Abstract][Full Text] [Related]
7. Knowledge and psychosocial impact of genetic counseling and multigene panel testing among individuals with ovarian cancer.
Pozzar RA; Hong F; Xiong N; Stopfer JE; Nayak MM; Underhill-Blazey M
Fam Cancer; 2022 Jan; 21(1):35-47. PubMed ID: 33751319
[TBL] [Abstract][Full Text] [Related]
8. Rates and Classification of Variants of Uncertain Significance in Hereditary Disease Genetic Testing.
Chen E; Facio FM; Aradhya KW; Rojahn S; Hatchell KE; Aguilar S; Ouyang K; Saitta S; Hanson-Kwan AK; Capurro NN; Takamine E; Jamuar SS; McKnight D; Johnson B; Aradhya S
JAMA Netw Open; 2023 Oct; 6(10):e2339571. PubMed ID: 37878314
[TBL] [Abstract][Full Text] [Related]
9. Family communication and patient distress after germline genetic testing in individuals with pancreatic ductal adenocarcinoma.
Peters MLB; Stobie L; Dudley B; Karloski E; Allen K; Speare V; Dolinsky JS; Tian Y; DeLeonardis K; Krejdovsky J; Button A; Lim C; Borazanci E; Brand R; Tung N
Cancer; 2019 Jul; 125(14):2488-2496. PubMed ID: 30980401
[TBL] [Abstract][Full Text] [Related]
10. Ancestry-specific hereditary cancer panel yields: Moving toward more personalized risk assessment.
Roberts ME; Susswein LR; Janice Cheng W; Carter NJ; Carter AC; Klein RT; Hruska KS; Marshall ML
J Genet Couns; 2020 Aug; 29(4):598-606. PubMed ID: 32227564
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic Outcomes of Concurrent DNA and RNA Sequencing in Individuals Undergoing Hereditary Cancer Testing.
Horton C; Hoang L; Zimmermann H; Young C; Grzybowski J; Durda K; Vuong H; Burks D; Cass A; LaDuca H; Richardson ME; Harrison S; Chao EC; Karam R
JAMA Oncol; 2024 Feb; 10(2):212-219. PubMed ID: 37924330
[TBL] [Abstract][Full Text] [Related]
12. Psychosocial problems in women attending French, German and Spanish genetics clinics before and after targeted or multigene testing results: an observational prospective study.
Brédart A; Kop JL; Dick J; Cano A; De Pauw A; Anota A; Brunet J; Devilee P; Stoppa-Lyonnet D; Schmutzler R; Dolbeault S
BMJ Open; 2019 Sep; 9(9):e029926. PubMed ID: 31551380
[TBL] [Abstract][Full Text] [Related]
13. Racial and ethnic variation in multigene panel testing in a cohort of BRCA1/2-negative individuals who had genetic testing in a large urban comprehensive cancer center.
Tatineni S; Tarockoff M; Abdallah N; Purrington KS; Assad H; Reagle R; Petrucelli N; Simon MS
Cancer Med; 2022 Mar; 11(6):1465-1473. PubMed ID: 35040284
[TBL] [Abstract][Full Text] [Related]
14. Analysis of hereditary cancer syndromes by using a panel of genes: novel and multiple pathogenic mutations.
Tsaousis GN; Papadopoulou E; Apessos A; Agiannitopoulos K; Pepe G; Kampouri S; Diamantopoulos N; Floros T; Iosifidou R; Katopodi O; Koumarianou A; Markopoulos C; Papazisis K; Venizelos V; Xanthakis I; Xepapadakis G; Banu E; Eniu DT; Negru S; Stanculeanu DL; Ungureanu A; Ozmen V; Tansan S; Tekinel M; Yalcin S; Nasioulas G
BMC Cancer; 2019 Jun; 19(1):535. PubMed ID: 31159747
[TBL] [Abstract][Full Text] [Related]
15. Role of psychological background in cancer susceptibility genetic testing distress: It is not only about a positive result.
López-Fernández A; Villacampa G; Salinas M; Grau E; Darder E; Carrasco E; Solanes A; Velasco A; Torres M; Munté E; Iglesias S; Torres-Esquius S; Tuset N; Diez O; Lázaro C; Brunet J; Corbella S; Balmaña J
J Genet Couns; 2023 Aug; 32(4):778-787. PubMed ID: 36748747
[TBL] [Abstract][Full Text] [Related]
16. Discoveries beyond BRCA1/2: Multigene testing in an Asian multi-ethnic cohort suspected of hereditary breast cancer syndrome in the real world.
Ow SGW; Ong PY; Lee SC
PLoS One; 2019; 14(3):e0213746. PubMed ID: 30875412
[TBL] [Abstract][Full Text] [Related]
17. Psychological distress related to BRCA testing in ovarian cancer patients.
Bjørnslett M; Dahl AA; Sørebø Ø; Dørum A
Fam Cancer; 2015 Dec; 14(4):495-504. PubMed ID: 25980896
[TBL] [Abstract][Full Text] [Related]
18. Health behaviors among unaffected participants following receipt of variants of uncertain significance in cardiomyopathy-associated genes.
Miller IM; Lewis KL; Lawal TA; Ng D; Johnston JJ; Biesecker BB; Biesecker LG
Genet Med; 2019 Mar; 21(3):748-752. PubMed ID: 29997389
[TBL] [Abstract][Full Text] [Related]
19. Longitudinal outcomes with cancer multigene panel testing in previously tested BRCA1/2 negative patients.
Bradbury AR; Egleston BL; Patrick-Miller LJ; Rustgi N; Brandt A; Brower J; DiGiovanni L; Fetzer D; Berkelbach C; Long JM; Powers J; Stopfer JE; Domchek SM
Clin Genet; 2020 Apr; 97(4):601-609. PubMed ID: 32022897
[TBL] [Abstract][Full Text] [Related]
20. Clinical Multigene Panel Testing Identifies Racial and Ethnic Differences in Germline Pathogenic Variants Among Patients With Early-Onset Colorectal Cancer.
Seagle HM; Keller SR; Tavtigian SV; Horton C; Holowatyj AN
J Clin Oncol; 2023 Sep; 41(26):4279-4289. PubMed ID: 37319387
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]